Sukumar Sakamuri

Sukumar Sakamuri

Company: Aro Biotherapeutics

Job title: Chief Technology Officer

Seminars:

Workshop A: Outlining Progress From Within the Oligonucleotide Conjugate World & Discussing Unique Challenges With Their Development 9:00 am - 12:00 pm

Although the first wave of next-generation conjugates was primarily immunestimulating orientated, there is a growing abundance of oligonucleotide conjugate drugs in development. Conjugating oligonucleotide payloads helps overcome traditional oligonucleotide delivery challenges, but with only a handful of these drugs so far entering the clinic there still is work to do to progress this modality forward.…Read more

day: Pre-Conference Day Track A

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.